I would expect the patent to be along the lines of "Use of a low-THC cannabinoid medication to treat neurological conditions". Of course that's ridiculously general and a more specific application might be required by patent offices, or it might be hard to defend. But the patent beagles would know exactly how the application should be formulated.
The company has already tied up Dolce / NTI-64 through a licencing agreement.
So while it would be open to anybody to develop an alternative low-THC strain of cannabis the patent would form a second line of defense concerning its application in medicine.
- Forums
- ASX - By Stock
- Ann: Neurotech Completes $9.0M Placement
I would expect the patent to be along the lines of "Use of a...
-
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NTI (ASX) to my watchlist
|
|||||
Last
7.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $72.23M |
Open | High | Low | Value | Volume |
7.3¢ | 7.3¢ | 7.1¢ | $31.10K | 437.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 92200 | 7.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.2¢ | 100000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 92200 | 0.071 |
5 | 283708 | 0.070 |
2 | 223000 | 0.069 |
1 | 50000 | 0.068 |
1 | 9513 | 0.066 |
Price($) | Vol. | No. |
---|---|---|
0.072 | 100000 | 1 |
0.073 | 176972 | 2 |
0.075 | 35347 | 1 |
0.078 | 176655 | 2 |
0.079 | 264102 | 2 |
Last trade - 13.51pm 26/08/2024 (20 minute delay) ? |
Featured News
NTI (ASX) Chart |